title: Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53.
abstract: Osteopontin (OPN) is highly expressed in cancer patients and plays important roles in many stages of tumor progression, such as anti-apoptosis, proliferation, and metastasis. From functional screening of human cDNA library, we isolated OPN as a caspase-8 substrate that regulates cell death during hypoxia/reoxygenation (Hyp/RO). In vitro cleavage assays demonstrate that OPN is cleaved at Asp-135 and Asp-157 by caspase-8. Cellular cleavage of OPN is observed in apoptotic cells exposed to Hyp/RO among various apoptotic stimuli and its cleavage is blocked by zVAD or IETD caspase inhibitor. Further, over-expression of OPN, the form with secretion signal, inhibits Hyp/RO-induced cell death. Caspase cleavage-defective OPN mutant (OPN D135A/D157A) is more efficient to suppress Hyp/RO-induced cell death than wild-type OPN. OPN D135A/D157A sustains AKT activity to increase cell viability through inhibition of caspase-9 during Hyp/RO. In addition, OPN is highly induced in some tumor cells during Hyp/RO, such as HeLa and Huh-7 cells, which is associated with their resistance to Hyp/RO by sustaining AKT activity. Notably, OPN C-terminal cleavage fragment produced by caspase-8 is detected in the nucleus. Plasmid-encoded expression of OPN C-terminal cleavage fragment increases p53 protein level and induces apoptosis of wild-type mouse embryonic fibroblast cells, but not p53(-/-) mouse embryonic fibroblast cells. These observations suggest that the protective function of OPN during Hyp/RO is inactivated via the proteolytic cleavage by caspase-8 and its cleavage product subsequently induces cell death via p53, postulating caspase-8 as a negative regulator of tumorigenic activity of OPN.
authors.affiliation: Creative Research Initiative Acceleration Research, School of Biological Science/Bio-Max Institute, Seoul National University, Seoul 151-747, Korea.
authors.forename: Hyo-Jin
authors.initials: HJ
authors.lastname: Kim
authors.forename: Ho-June
authors.initials: HJ
authors.lastname: Lee
authors.forename: Joon-Il
authors.initials: JI
authors.lastname: Jun
authors.forename: Yumin
authors.initials: Y
authors.lastname: Oh
authors.forename: Seon-Guk
authors.initials: SG
authors.lastname: Choi
authors.forename: Hyunjoo
authors.initials: H
authors.lastname: Kim
authors.forename: Chul-Woong
authors.initials: CW
authors.lastname: Chung
authors.forename: In-Ki
authors.initials: IK
authors.lastname: Kim
authors.forename: Il-Sun
authors.initials: IS
authors.lastname: Park
authors.forename: Han-Jung
authors.initials: HJ
authors.lastname: Chae
authors.forename: Hyung-Ryong
authors.initials: HR
authors.lastname: Kim
authors.forename: Yong-Keun
authors.initials: YK
authors.lastname: Jung
mesh_terms: D017209:Apoptosis / Q000502:physiology*; D015153:Blotting, Western; D053181:Caspase 8 / Q000378:metabolism*; D015687:Cell Hypoxia / Q000502:physiology*; D003720:Densitometry; D006367:HeLa Cells; D006801:Humans; D053495:Osteopontin / Q000235:genetics / Q000378:metabolism*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D016159:Tumor Suppressor Protein p53; D053495:Osteopontin; D053181:Caspase 8
references.citation: Cell. 2008 Jun 13;133(6):994-1005
references.pmid: 18555776
references.citation: Proc Natl Acad Sci U S A. 2008 May 20;105(20):7235-9
references.pmid: 18480255
references.citation: Science. 2000 Feb 4;287(5454):860-4
references.pmid: 10657301
references.citation: J Cell Physiol. 2000 Jul;184(1):118-30
references.pmid: 10825241
references.citation: Mol Cell Biol. 2004 Aug;24(15):6592-607
references.pmid: 15254227
references.citation: Nat Rev Cancer. 2008 Mar;8(3):212-26
references.pmid: 18292776
references.citation: Science. 1998 Nov 13;282(5392):1318-21
references.pmid: 9812896
references.citation: J Biol Chem. 2001 Dec 7;276(49):46024-30
references.pmid: 11590166
references.citation: J Biol Chem. 1999 May 14;274(20):14255-61
references.pmid: 10318846
references.citation: Neurobiol Dis. 2001 Feb;8(1):162-72
references.pmid: 11162250
references.citation: Oncogene. 2008 Jun 26;27(28):3957-66
references.pmid: 18317451
references.citation: Cell Death Differ. 2008 Sep;15(9):1350-5
references.pmid: 18566604
references.citation: Oncogene. 2003 Apr 17;22(15):2236-47
references.pmid: 12700660
references.citation: Cell. 1998 Aug 21;94(4):491-501
references.pmid: 9727492
references.citation: Am J Physiol Cell Physiol. 2007 Feb;292(2):C919-26
references.pmid: 17005603
references.citation: Bone. 2006 Jun;38(6):749-57
references.pmid: 16412713
references.citation: Nat Med. 2000 May;6(5):529-35
references.pmid: 10802708
references.citation: J Cell Biol. 1997 Oct 20;139(2):327-38
references.pmid: 9334338
references.citation: Biochem Biophys Res Commun. 2007 Nov 23;363(3):745-50
references.pmid: 17904098
references.citation: Nat Immunol. 2006 May;7(5):498-506
references.pmid: 16604075
references.citation: Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4331-6
references.pmid: 11917123
references.citation: Biochem Biophys Res Commun. 2007 May 18;356(4):1056-61
references.pmid: 17400183
references.citation: Oncogene. 2005 Jan 6;24(1):141-7
references.pmid: 15531912
references.citation: Oncogene. 2003 Nov 6;22(50):8168-77
references.pmid: 14603257
references.citation: J Biol Chem. 2003 Aug 1;278(31):28593-606
references.pmid: 12771144
references.citation: J Cell Biol. 2008 Aug 25;182(4):675-84
references.pmid: 18710920
references.citation: Genes Dev. 1999 Oct 1;13(19):2514-26
references.pmid: 10521396
references.citation: Cell. 2008 May 16;133(4):693-703
references.pmid: 18485876
references.citation: Nat Rev Cancer. 2008 Jun;8(6):425-37
references.pmid: 18500244
references.citation: Oncogene. 2007 Apr 26;26(19):2809-14
references.pmid: 17086211
references.citation: J Cell Physiol. 1994 Jul;160(1):61-8
references.pmid: 7517407
references.citation: Mol Cell Biol. 2000 Aug;20(15):5665-79
references.pmid: 10891503
references.citation: Nat Cell Biol. 2007 Nov;9(11):1303-10
references.pmid: 17952061
references.citation: Oncogene. 2005 May 5;24(20):3268-73
references.pmid: 15782135
references.citation: J Clin Invest. 2001 May;107(9):1055-61
references.pmid: 11342566
references.citation: Oncogene. 2005 Jan 20;24(4):688-96
references.pmid: 15592525
references.citation: Acta Orthop Scand Suppl. 1995 Oct;266:61-5
references.pmid: 8553864
references.citation: J Biol Chem. 2002 Jun 14;277(24):21843-50
references.pmid: 11923280
references.citation: J Biol Chem. 2002 Aug 30;277(35):31639-45
references.pmid: 12063258
references.citation: Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4838-43
references.pmid: 18359851
references.citation: Trends Cell Biol. 2006 Feb;16(2):79-87
references.pmid: 16406521